MetA Mutant Engineering for Stable O-Succinyl Homoserine Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing O-succinyl homoserine suffer from low yield and stability issues due to feedback inhibition by methionine, leading to insufficient production of O-succinyl homoserine in microorganisms, which is crucial for economical methionine production.

Innovation Solution

A mutated O-succinyl homoserine transferase polypeptide with specific amino acid substitutions at positions 313 and 176, derived from Corynebacterium glutamicum, is used to enhance the conversion activity of O-succinyl homoserine, overcoming feedback inhibition and improving stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If feedback inhibition of metA is removed to increase O-succinyl homoserine production, then production yield is improved, but enzymatic stability deteriorates

Engineering Contradiction:
ImproveO-succinyl homoserine production yieldVSAvoidenzymatic stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying specific amino acid residues in the MetA enzyme structure (positions 176 and 313) to alter its regulatory properties. The mutations R176K/E313K or R176K/E313Q change the enzyme's feedback inhibition characteristics and stability parameters, enabling high production yield while maintaining enzymatic stability through precise structural modification rather than complete removal of regulation.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If MetA activity is increased to overcome feedback inhibition, then O-succinyl homoserine production is improved, but protein stability further deteriorates

Engineering Contradiction:
ImproveO-succinyl homoserine productionVSAvoidprotein stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent resolves this contradiction by making precise parameter changes to the enzyme structure through site-directed mutagenesis at positions 176 and 313. These specific amino acid substitutions optimize the balance between catalytic activity and protein stability, allowing the enzyme to maintain high activity for O-succinyl homoserine production while preserving structural integrity and stability.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If conventional MetA is used in methionine-producing strains, then methionine synthesis is maintained, but O-succinyl homoserine accumulation is limited due to feedback inhibition

Engineering Contradiction:
ImproveO-succinyl homoserine concentrationVSAvoidfeedback inhibition effect
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent applies parameter changes by introducing specific mutations (R176K/E313K or R176K/E313Q) that alter the feedback inhibition parameters of MetA. This enables the enzyme to maintain high catalytic activity even in the presence of methionine, allowing O-succinyl homoserine to accumulate to high concentrations while the strain continues to produce methionine effectively.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutated polypeptide significantly increases O-succinyl homoserine production, making it suitable for high-yield production of methionine as an alternative to conventional chemical synthesis pathways.

Implementation Method 1

homoserine O-succinyl transferase (MetA), as an enzyme involved in the synthesis of O-succinyl homoserine, by binding a succinyl group of succinyl-CoA to homoserine

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP3647415B1Novel o-succinyl homoserine transferase mutant and method for producing o-succinyl homoserine using same
Publication Date: 2025.12.03 CJ CHEILJEDANG CORP
  • EP3647415B1 patent drawing
  • EP3647415B1 patent drawing
  • EP3647415B1 patent drawing

AI summary

The present disclosure relates to an O-succinyl homoserine transferase mutant, a polynucleotide encoding the same, a microorganism including the mutant, and a method of producing O-succinyl homoserine using the microorganism.